Trends in Manufacturing eBook
Read the article:
Implementing Continuous Bioprocessing: From Theory to Practice
Read the eBook:
Pharmaceutical Technology’s Trends in Manufacturing eBook
The struggle to implement continuous biomanufacturing at GMP level is slowly advancing.
Tashatuvango/Stock.adobe.com
The evolution of technologies on the bioprocessing front is enabling an ability to perform continuous processing for biologic production. Although successes have been shown at small scale, challenges arise when translating continuous processes to large-scale good manufacturing practice (GMP) level. With the help of technological advances and innovative thinking, however, the potential to implement GMP-scale continuous bioprocessing is getting closer to reality. This article looks at real-world experiences of some companies that tested out the implementation of continuous manufacturing systems for GMP-scale biologics manufacture.
Read the article:
Implementing Continuous Bioprocessing: From Theory to Practice
Read the eBook:
Pharmaceutical Technology’s Trends in Manufacturing eBook
Read this article in Pharmaceutical Technology’s May 2022 Trends in Manufacturing eBook.
Feliza Mirasol is the science editor for Pharmaceutical Technology and Pharmaceutical Technology Europe.
Pharmaceutical Technology
eBook: Trends in Manufacturing, May 2022
May 2022
Pages: 36–38
When referring to this article, please cite it as F. Mirasol, “Implementing Continuous Bioprocessing: From Theory to Practice," Pharmaceutical Technology Trends in Manufacturing eBook (May 2022).
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.